152 related articles for article (PubMed ID: 10348150)
1. Hydroxyurea-induced acute interstitial pneumonitis in a patient with essential thrombocythemia.
Quintás-Cardama A; Pérez-Encinas M; Gonzalez S; Bendaña A; Bello JL
Ann Hematol; 1999 Apr; 78(4):187-8. PubMed ID: 10348150
[TBL] [Abstract][Full Text] [Related]
2. Hydroxyurea-induced interstitial pneumonitis: case report and review of the literature.
Internullo M; Giannelli V; Sardo L; Antonaglia C; Villani T; Angelici E; Palange P
Eur Rev Med Pharmacol Sci; 2014; 18(2):190-3. PubMed ID: 24488907
[TBL] [Abstract][Full Text] [Related]
3. Myelodysplastic syndrome and secondary acute leukemia after treatment of essential thrombocythemia with hydroxyurea.
van den Anker-Lugtenburg PJ; Sizoo W
Am J Hematol; 1990 Feb; 33(2):152. PubMed ID: 2301374
[No Abstract] [Full Text] [Related]
4. [Drug-induced interstitial pneumonitis in essential thrombocythemia treated with anagrelide].
Kajiguchi T; Kamoshita S; Ito T; Yagi M; Kimura T
Rinsho Ketsueki; 2017; 58(2):119-125. PubMed ID: 28321088
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyurea-induced Pneumonitis in a Patient with Chronic Myelomonocytic Leukemia: An Autopsy Case.
Imai H; Matsumura N; Yamazaki Y; Kanayama Y; Masuda T; Kuwako T; Kamide Y; Tomizawa T; Matsumoto S; Mitsui T; Kaira K; Ono A; Koga Y; Shibusawa N; Sunaga N; Hisada T; Yokoo H; Yamada M
Intern Med; 2015; 54(24):3171-6. PubMed ID: 26666606
[TBL] [Abstract][Full Text] [Related]
6. [A lower-leg ulcer during hydroxyurea therapy for essential thrombocythemia].
Iwama H; Kawakubo K; Nehashi Y; Kuriyama Y; Iwase O; Ohyashiki K; Watanabe K; Ebihara Y; Toyama K
Gan To Kagaku Ryoho; 1996 Jun; 23(7):937-9. PubMed ID: 8678547
[TBL] [Abstract][Full Text] [Related]
7. Multiple myeloma following essential thrombocythemia.
Ben Youssef Y; Gmidène A; Bouabid Z; Bouallegui S; Sriha B; Zaier M; Sennana H; Khelif A
Ann Biol Clin (Paris); 2013; 71(4):457-60. PubMed ID: 23906574
[TBL] [Abstract][Full Text] [Related]
8. Implications of the consensus definition of clinical resistance and intolerance to hydroxyurea for clinical practice.
Reilly JT
Eur J Haematol Suppl; 2007 Oct; (68):32-4. PubMed ID: 17727564
[No Abstract] [Full Text] [Related]
9. Plasma cell leukemia occurring in a patient with thrombocythemia treated with hydroxyurea and busulphan.
Candoni A; Tiribelli M; Fanin R
Leuk Lymphoma; 2004 Apr; 45(4):821-4. PubMed ID: 15160964
[TBL] [Abstract][Full Text] [Related]
10. Hydroxyurea as a cause of drug fever.
Braester A; Quitt M
Acta Haematol; 2000; 104(1):50-1. PubMed ID: 11111124
[TBL] [Abstract][Full Text] [Related]
11. When and how to treat essential thrombocythemia.
Barbui T; Finazzi G
N Engl J Med; 2005 Jul; 353(1):85-6. PubMed ID: 16000360
[No Abstract] [Full Text] [Related]
12. Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.
Harrison CN; Campbell PJ; Buck G; Wheatley K; East CL; Bareford D; Wilkins BS; van der Walt JD; Reilly JT; Grigg AP; Revell P; Woodcock BE; Green AR;
N Engl J Med; 2005 Jul; 353(1):33-45. PubMed ID: 16000354
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of long-term use of hydroxyurea in young patients with essential thrombocythemia and a high risk of thrombosis.
Finazzi G; Ruggeri M; Rodeghiero F; Barbui T
Blood; 2003 May; 101(9):3749. PubMed ID: 12707224
[No Abstract] [Full Text] [Related]
14. Hydroxyurea-induced hemolytic anemia in a patient with essential thrombocythemia.
Jabr FI; Shamseddine A; Taher A
Am J Hematol; 2004 Dec; 77(4):374-6. PubMed ID: 15558807
[TBL] [Abstract][Full Text] [Related]
15. Transition of essential thrombocythemia to megakaryoblastic leukemia after long-term therapy with sequential busulfan, pipobroman and hydroxyurea.
Sironi M; Bertola G; Lodato A; Spinelli M; Sciariada L
Acta Haematol; 2003; 109(3):161-2. PubMed ID: 12714827
[No Abstract] [Full Text] [Related]
16. Nail changes after chemotherapy.
Las Heras G; Juncà Piera J
Haematologica; 1998 Aug; 83(8):748. PubMed ID: 9793260
[No Abstract] [Full Text] [Related]
17. Efficacy and safety of hydroxyurea in patients with essential thrombocythemia.
Finazzi G; Barbui T
Pathol Biol (Paris); 2001 Mar; 49(2):167-9. PubMed ID: 11317964
[TBL] [Abstract][Full Text] [Related]
18. Acute myeloid leukemia evolving from essential thrombocythemia in two patients treated with hydroxyurea.
Furgerson JL; Vukelja SJ; Baker WJ; O'Rourke TJ
Am J Hematol; 1996 Feb; 51(2):137-40. PubMed ID: 8579054
[TBL] [Abstract][Full Text] [Related]
19. Anagrelide compared with hydroxyurea in essential thrombocythemia: a meta-analysis.
Samuelson B; Chai-Adisaksopha C; Garcia D
J Thromb Thrombolysis; 2015 Nov; 40(4):474-9. PubMed ID: 25894476
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyurea-induced acute interstitial lung disease.
Kavuru MS; Gadsden T; Lichtin A; Gephardt G
South Med J; 1994 Jul; 87(7):767-9. PubMed ID: 8023217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
